Lombardi Lucia, Li Jiaxu, Williams Daryl R
Department of Chemical Engineering, South Kensington Campus, Imperial College London, London SW7 2AZ, UK.
Pharmaceutics. 2024 Nov 18;16(11):1468. doi: 10.3390/pharmaceutics16111468.
This review explores the potential of peptide-based biomaterials to enhance biomedical applications through self-assembly, biological responsiveness, and selective targeting. Peptides are presented as versatile agents for antimicrobial activity and drug delivery, with recent approaches incorporating antimicrobial peptides into self-assembling systems to improve effectiveness and reduce resistance. The review also covers peptide-based nanocarriers for cancer drug delivery, highlighting their improved stability, targeted delivery, and reduced side effects. The focus of this work is on the bioactive properties of peptides, particularly in infection control and drug delivery, rather than on their structural design or material characteristics. Additionally, it examines the role of peptidomimetics in broadening biomaterial applications and enhancing resistance to enzymatic degradation. Finally, the review discusses the commercial prospects and challenges of translating peptide biomaterials into clinical applications.
本综述探讨了基于肽的生物材料通过自组装、生物响应性和选择性靶向增强生物医学应用的潜力。肽被认为是具有抗菌活性和药物递送功能的多功能试剂,最近的方法是将抗菌肽纳入自组装系统以提高有效性并降低耐药性。该综述还涵盖了用于癌症药物递送的基于肽的纳米载体,强调了它们提高的稳定性、靶向递送和减少的副作用。这项工作的重点是肽的生物活性特性,特别是在感染控制和药物递送方面,而不是它们的结构设计或材料特性。此外,它研究了肽模拟物在拓宽生物材料应用和增强抗酶降解能力方面的作用。最后,该综述讨论了将肽生物材料转化为临床应用的商业前景和挑战。